It is important to stay consistent with your dosing schedule for both medications
Worldwide, type 2 diabetes affects more than 500 million people, and obesity affects over 890 million (3,4)
This limitation necessitates higher and more frequent dosages, leading to an increased economic burden on patients 6
Collectively, these factors highlight the need for carefully designed therapies that can selectively target GSH in tumors while minimizing toxicity and overcoming adaptive resistance mechanisms
Therefore, the siRNA#1 of either GLP-1R or PKA was used in the following experiments
Este proyecto que integra tambin a una asociacin de pacientes, crear clnicas de diabetes en el nivel primario de salud donde se atendern nios con diabetes tipo 1 de manera gratuita y se capacitarn a mdicos de este nivel para un mejor abordaje de la enfermedad